{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:47:44Z","timestamp":1765079264533},"reference-count":40,"publisher":"Codon Publications","issue":"4","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Allergologia et Immunopathologia"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/j.aller.2014.05.005","type":"journal-article","created":{"date-parts":[[2014,9,6]],"date-time":"2014-09-06T05:24:30Z","timestamp":1409981070000},"page":"403-408","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["IgG anti-IgA antibodies in paediatric antibody-deficient patients receiving intravenous immunoglobulin"],"prefix":"10.15586","volume":"43","author":[{"given":"B.","family":"Torabi Sagvand","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Mirminachi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Shokouhfar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Keihanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Amirzargar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Mahdaviani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Aghamohammadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"6228","reference":[{"key":"10.1016\/j.aller.2014.05.005_bib0005","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s10875-006-9047-x","article-title":"Frequency and clinical manifestations of patients with primary immunodeficiency disorders in Iran: update from the Iranian Primary Immunodeficiency Registry","volume":"26","author":"Rezaei","year":"2006","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0010","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1056\/NEJM199107113250207","article-title":"The use of intravenous immune globulin in immunodeficiency diseases","volume":"325","author":"Buckley","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2014.05.005_bib0015","doi-asserted-by":"crossref","first-page":"435","DOI":"10.7326\/0003-4819-101-4-435","article-title":"Efficacy of intravenous immunoglobulin in primary humoral immunodeficiency disease","volume":"101","author":"Cunningham-Rundles","year":"1984","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.aller.2014.05.005_bib0020","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1007\/BF00919386","article-title":"Long-term use of IgA-depleted intravenous immunoglobulin in immunodeficient subjects with anti-IgA antibodies","volume":"13","author":"Cunningham-Rundles","year":"1993","journal-title":"J Clin Immunol"},{"issue":"Suppl 1","key":"10.1016\/j.aller.2014.05.005_bib0025","first-page":"79","article-title":"Side-effects of intravenous immune globulins","volume":"97","author":"Duhem","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0030","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1136\/adc.74.6.527","article-title":"Treatment of hypogammaglobulinaemia with intravenous immunoglobulin, 1973\u201393","volume":"74","author":"Skull","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/j.aller.2014.05.005_bib0035","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1016\/j.jaci.2013.02.028","article-title":"Controversies in IgG replacement therapy in patients with antibody deficiency diseases","volume":"131","author":"Gelfand","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0040","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1365-3083.1983.tb00885.x","article-title":"Anti-IgA in selective IgA deficiency. In vitro effects and Ig subclass pattern of human anti-IgA","volume":"18","author":"Hammarstrom","year":"1983","journal-title":"Scand J Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0045","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/BF00915419","article-title":"Immunoglobulin prophylaxis in patients with antibody deficiency syndromes and anti-IgA antibodies","volume":"7","author":"Bjorkander","year":"1987","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0050","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1023\/A:1006650812886","article-title":"IgG anti-IgA subclasses in common variable immunodeficiency and association with severe adverse reactions to intravenous immunoglobulin therapy","volume":"20","author":"de Albuquerque Campos","year":"2000","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0055","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jcp.54.5.337","article-title":"IgA deficiency: what we should-or should not-be doing","volume":"54","author":"Lilic","year":"2001","journal-title":"J Clin Pathol"},{"key":"10.1016\/j.aller.2014.05.005_bib0060","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0090-1229(86)90133-9","article-title":"Use of an IgA-depleted intravenous immunoglobulin in a patient with an anti-IgA antibody","volume":"38","author":"Cunningham-Rundles","year":"1986","journal-title":"Clin Immunol Immunopathol"},{"issue":"Suppl 1","key":"10.1016\/j.aller.2014.05.005_bib0065","first-page":"11","article-title":"Intravenous immune globulin in primary immunodeficiency","volume":"97","author":"Haeney","year":"1994","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0070","first-page":"213","article-title":"Substitution therapy in immunodeficient patients with anti-IgA antibodies or severe adverse reactions to previous immunoglobulin therapy","volume":"61","author":"Eijkhout","year":"2003","journal-title":"Neth J Med"},{"key":"10.1016\/j.aller.2014.05.005_bib0075","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1016\/j.jaci.2011.06.047","article-title":"The role of anti-IgA antibodies in causing adverse reactions to gamma globulin infusion in immunodeficient patients: a comprehensive review of the literature","volume":"129","author":"Rachid","year":"2012","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0080","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1006\/clim.1999.4799","article-title":"Diagnostic criteria for primary immunodeficiencies. Representing PAGID (Pan-American Group for Immunodeficiency) and ESID (European Society for Immunodeficiencies)","volume":"93","author":"Conley","year":"1999","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0085","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/0090-1229(88)90072-4","article-title":"Anti-IgA antibodies in selective IgA deficiency and in primary immunodeficient patients treated with gamma-globulin","volume":"47","author":"Ferreira","year":"1988","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.aller.2014.05.005_bib0090","first-page":"838","article-title":"Healthy blood donors with selective absence of immunoglobulin A: prevention of anaphylactic transfusion reactions caused by antibodies to IgA","volume":"85","author":"Vyas","year":"1975","journal-title":"J Lab Clin Med"},{"key":"10.1016\/j.aller.2014.05.005_bib0095","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1182\/blood.V84.6.2031.2031","article-title":"Hemagglutination assays for the diagnosis and prevention of IgA anaphylactic transfusion reactions","volume":"84","author":"Sandler","year":"1994","journal-title":"Blood"},{"key":"10.1016\/j.aller.2014.05.005_bib0100","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1056\/NEJM198512263132602","article-title":"Anti-IgA antibodies in pregnancy","volume":"313","author":"Petty","year":"1985","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2014.05.005_bib0105","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.clim.2006.10.002","article-title":"Anti-IgA antibodies in common variable immunodeficiency (CVID): diagnostic workup and therapeutic strategy","volume":"122","author":"Horn","year":"2007","journal-title":"Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0110","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1046\/j.1423-0410.2001.00047.x","article-title":"Rapid detection of antibodies to immunoglobulin A molecules by using the particle gel immunoassay","volume":"81","author":"Salama","year":"2001","journal-title":"Vox Sang"},{"key":"10.1016\/j.aller.2014.05.005_bib0115","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1093\/ajcp\/80.2.210","article-title":"Selective IgA deficiency in blood donors","volume":"80","author":"Clark","year":"1983","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.aller.2014.05.005_bib0120","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1744-313X.1977.tb00912.x","article-title":"Anti-IgA antibodies of limited specificity in healthy IgA deficient subjects","volume":"4","author":"Koistinen","year":"1977","journal-title":"J Immunogenet"},{"key":"10.1016\/j.aller.2014.05.005_bib0125","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1385\/CRIAI:29:3:173","article-title":"Intravenous immunoglobulin: adverse effects and safe administration","volume":"29","author":"Orbach","year":"2005","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1046\/j.1365-2249.1998.00571.x","article-title":"Induction of unresponsiveness against IgA in IgA-deficient patients on subcutaneous immunoglobulin infusion therapy","volume":"112","author":"Sundin","year":"1998","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0135","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1007\/s10875-012-9720-1","article-title":"Home-based subcutaneous immunoglobulin versus hospital-based intravenous immunoglobulin in treatment of primary antibody deficiencies: systematic review and meta analysis","volume":"32","author":"Abolhassani","year":"2012","journal-title":"J Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0140","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1586\/eci.10.104","article-title":"Indications and safety of intravenous and subcutaneous immunoglobulin therapy","volume":"7","author":"Rezaei","year":"2011","journal-title":"Expert Rev Clin Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0145","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1111\/j.1365-2362.1973.tb00357.x","article-title":"The significance of the presence of anti-IgA antibodies in individuals with an IgA deficiency","volume":"3","author":"Nadorp","year":"1973","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/j.aller.2014.05.005_bib0150","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/0090-1229(77)90068-X","article-title":"Comparative frequencies of anti-IgA antibodies among patients with anaphylactic transfusion reactions and among normal blood donors","volume":"7","author":"Rivat","year":"1977","journal-title":"Clin Immunol Immunopathol"},{"key":"10.1016\/j.aller.2014.05.005_bib0155","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.autrev.2012.02.006","article-title":"Intravenous immunoglobulin: exploiting the potential of natural antibodies","volume":"11","author":"Kaveri","year":"2012","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.aller.2014.05.005_bib0160","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.autrev.2008.04.014","article-title":"Modulation of human dendritic cell maturation and function by natural IgG antibodies","volume":"7","author":"Elluru","year":"2008","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.aller.2014.05.005_bib0165","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0198-8859(97)00100-6","article-title":"Innate natural antibodies. Primary roles indicated by specific epitopes","volume":"55","author":"Rodman","year":"1997","journal-title":"Hum Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0170","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1056\/NEJM198602273140907","article-title":"Anaphylactic reactions after gamma globulin administration in patients with hypogammaglobulinemia. Detection of IgE antibodies to IgA","volume":"314","author":"Burks","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.aller.2014.05.005_bib0175","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/j.1365-2222.1986.tb01966.x","article-title":"Immunoglobulin substitution therapy in a patient with primary hypogammaglobulinaemia and anti-IgA antibodies","volume":"16","author":"Hedderich","year":"1986","journal-title":"Clin Allergy"},{"key":"10.1016\/j.aller.2014.05.005_bib0180","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2249.2007.03483.x","article-title":"Immune tolerance induction in patients with IgA anaphylactoid reactions following long-term intravenous IgG treatment","volume":"151","author":"Ahrens","year":"2008","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.aller.2014.05.005_bib0185","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1046\/j.1445-5994.2001.00053.x","article-title":"Safe and effective use of chromatographically purified intravenous immunoglobulin despite profound anti-IgA sensitization","volume":"31","author":"Limaye","year":"2001","journal-title":"Intern Med J"},{"key":"10.1016\/j.aller.2014.05.005_bib0190","first-page":"5","article-title":"Mechanisms of peripheral T cell tolerance","volume":"215","author":"van Parijs","year":"1998","journal-title":"Immunol Toler"},{"key":"10.1016\/j.aller.2014.05.005_bib0195","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.aller.2012.07.018","article-title":"Allergen-specific immunotherapy: update on immunological mechanisms","volume":"41","author":"Alvaro","year":"2013","journal-title":"Allergol Immunopathol"},{"key":"10.1016\/j.aller.2014.05.005_bib0200","first-page":"208","article-title":"Pediatric patients with common variable immunodeficiency: long-term follow-up","volume":"22","author":"Mohammadinejad","year":"2012","journal-title":"J Investig Allergol Clin Immunol"}],"container-title":["Allergologia et Immunopathologia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054614001256?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0301054614001256?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,12,31]],"date-time":"2020-12-31T22:50:04Z","timestamp":1609455004000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0301054614001256"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S0301054614001256"],"URL":"https:\/\/doi.org\/10.1016\/j.aller.2014.05.005","relation":{},"ISSN":["0301-0546"],"issn-type":[{"value":"0301-0546","type":"print"}],"subject":[],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IgG anti-IgA antibodies in paediatric antibody-deficient patients receiving intravenous immunoglobulin","name":"articletitle","label":"Article Title"},{"value":"Allergologia et Immunopathologia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.aller.2014.05.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 SEICAP. Published by Elsevier Espa\u00f1a, S.L. All rights reserved.","name":"copyright","label":"Copyright"}]}}